Background: Leukocytosis is a powerful predictor of incident chronic kidney disease (CKD) and related outcomes. However, the association between periodontitis measures and increased leukocytosis in the context of CKD has not been well described. We sought to identify which individual measures of periodontal disease may best associate with reduced estimated glomerular filtration rate (eGFR) and albuminuria, and to test if these measures were associated with increased leukocytosis in subjects with established CKD. Methods: We estimated, among 13,270 participants in the National Health and Nutrition Examination Survey III study, the associations between case-based definition of periodontitis, clinical attachment loss (CAL) and pocket depth (PD) as individual measures of periodontal disease, with renal function measures and leukocytosis. Results: In adjusted multivariate analyses, case-based definition of severe periodontitis was associated with albuminuria (β = 0.003, p = 0.01) but not with eGFR. However, CAL and PD were all individually associated with both albuminuria (β = 0.08, p < 0.001 and β = 0.06, p < 0.001, respectively) and eGFR (β = -0.05, p < 0.001 and β = -0.03, p < 0.001, respectively). We found significant associations between elevated CAL and PD with leukocytosis. Lastly, we found a marked association between the joint presence of CKD and elevated CAL or PD with leukocytosis (odds ratio (OR) 3.3, 95% confidence interval (CI) 1.4-7.5 and OR 3.2, 95% CI 1.1-9.7, respectively). Conclusion: Individual measures of periodontal disease are associated with renal function and heightened leukocytosis in CKD subjects. The significantly added inflammatory burden noted in CKD subjects with periodontal disease argue for targeting periodontitis treatment as part of our multifaceted approach to CKD patients.

Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH: Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000. J Am Soc Nephrol 2005;16:180-188.
Grubbs V, Plantinga LC, Crews DC, Bibbins-Domingo K, Saran R, Heung M, Patel PR, Burrows NR, Ernst KL, Powe NR: Vulnerable populations and the association between periodontal and chronic kidney disease. Clin J Am Soc Nephrol 2011;6:711-717.
Fisher MA, Taylor GW, West BT, McCarthy ET: Bidirectional relationship between chronic kidney and periodontal disease: a study using structural equation modeling. Kidney Int 2011;79:347-355.
Shankar A, Sun L, Klein BE, Lee KE, Muntner P, Nieto FJ, Tsai MY, Cruickshanks KJ, Schubert CR, Brazy PC, Coresh J, Klein R: Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int 2011;80:1231-1238.
Craig RG PA, Pecoits-Filho R, Levin NW, Kotanko P: Periodontal diseases and systemic inflammation. Semin Dial 2013;26:23-28.
Kshirsagar AV, Moss KL, Elter JR, Beck JD, Offenbacher S, Falk RJ: Periodontal disease is associated with renal insufficiency in the Atherosclerosis Risk In Communities (ARIC) study. Am J Kidney Dis 2005;45:650-657.
Suliman ME, Stenvinkel P: Contribution of inflammation to vascular disease in chronic kidney disease patients. Saudi J Kidney Dis Transpl 2008;19:329-345.
Mattila KJ, Nieminen MS, Valtonen VV, Rasi VP, Kesaniemi YA, Syrjala SL, Jungell PS, Isoluoma M, Hietaniemi K, Jokinen MJ: Association between dental health and acute myocardial infarction. BMJ 1989;298:779-781.
Buhlin K, Hultin M, Norderyd O, Persson L, Pockley AG, Pussinen PJ, Rabe P, Klinge B, Gustafsson A: Periodontal treatment influences risk markers for atherosclerosis in patients with severe periodontitis. Atherosclerosis 2009;206:518-522.
Offenbacher S, Beck JD, Moss K, Mendoza L, Paquette DW, Barrow DA, Couper DJ, Stewart DD, Falkner KL, Graham SP, Grossi S, Gunsolley JC, Madden T, Maupome G, Trevisan M, Van Dyke TE, Genco RJ: Results from the Periodontitis And Vascular Events (PAVE) study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol 2009;80:190-201.
Nakajima T, Yamazaki K: Periodontal disease and risk of atherosclerotic coronary heart disease. Odontology 2009;97:84-91.
Fisher MA, Borgnakke WS, Taylor GW: Periodontal disease as a risk marker in coronary heart disease and chronic kidney disease. Curr Opin Nephrol Hypertens 2010;19:519-526.
Erlinger TP, Tarver-Carr ME, Powe NR, Appel LJ, Coresh J, Eberhardt MS, Brancati FL: Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in us adults. Am J Kidney Dis 2003;42:256-263.
Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, Grimm RH Jr, Howard BV, Assaf AR, Prentice R: Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: The Women's Health Initiative Observational Study. Arch Intern Med 2005;165:500-508.
Agarwal R, Light RP: Patterns and prognostic value of total and differential leukocyte count in chronic kidney disease. Clin J Am Soc Nephrol 2011;6:1393-1399.
Willems JM, Trompet S, Blauw GJ, Westendorp RG, de Craen AJ: White blood cell count and C-reactive protein are independent predictors of mortality in the oldest old. J Gerontol A Biol Sci Med Sci 2010;65:764-768.
Sabatine MS, Morrow DA, Cannon CP, Murphy SA, Demopoulos LA, DiBattiste PM, McCabe CH, Braunwald E, Gibson CM: Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: A TACTICS-TIMI 18 (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy - Thrombolysis in Myocardial Infarction 18 Trial) substudy. J Am Coll Cardiol 2002;40:1761-1768.
Brown DW, Giles WH, Croft JB: White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 2001;54:316-322.
Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC: Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk In Communities (ARIC) study. Am J Kidney Dis 2009;53:596-605.
Smit JJ, Ottervanger JP, Slingerland RJ, Kolkman JJ, Suryapranata H, Hoorntje JC, Dambrink JH, Gosselink AT, de Boer MJ, Zijlstra F, van ‘t Hof AW: Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction. Am J Cardiol 2008;101:446-451.
Madjid M, Awan I, Willerson JT, Casscells SW: Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 2004;44:1945-1956.
Van Hemelrijck M, Holmberg L, Garmo H, Hammar N, Walldius G, Binda E, Lambe M, Jungner I: Association between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS study. Cancer Epidemiol Biomarkers Prev 2011;20:428-437.
Ruggiero C, Metter EJ, Cherubini A, Maggio M, Sen R, Najjar SS, Windham GB, Ble A, Senin U, Ferrucci L: White blood cell count and mortality in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol 2007;49:1841-1850.
Na HY, Shim JY, Lee HR, Jung DH, Kim HB, Park BJ, Jung RJ, Lee YJ: Sex differences in the relationship between leukocyte count and chronic kidney disease: The 2007 Korean National Health and Nutrition Examination Survey. J Womens Health (Larchmt) 2011;20:99-105.
Andriankaja OM, Genco RJ, Dorn J, Dmochowski J, Hovey K, Falkner KL, Scannapieco F, Trevisan M: The use of different measurements and definitions of periodontal disease in the study of the association between periodontal disease and risk of myocardial infarction. J Periodontol 2006;77:1067-1073.
Craig RG: Interactions between chronic renal disease and periodontal disease. Oral Dis 2008;14:1-7.
Fisher MA, Taylor GW, Papapanou PN, Rahman M, Debanne SM: Clinical and serologic markers of periodontal infection and chronic kidney disease. J Periodontol 2008;79:1670-1678.
Kshirsagar AV, Craig RG, Moss KL, Beck JD, Offenbacher S, Kotanko P, Klemmer PJ, Yoshino M, Levin NW, Yip JK, Almas K, Lupovici EM, Usvyat LA, Falk RJ: Periodontal disease adversely affects the survival of patients with end-stage renal disease. Kidney Int 2009;75:746-751.
Chen LP, Chiang CK, Chan CP, Hung KY, Huang CS: Does periodontitis reflect inflammation and malnutrition status in hemodialysis patients? Am J Kidney Dis 2006;47:815-822.
Eke PI, Thornton-Evans GO, Wei L, Borgnakke WS, Dye BA: Accuracy of NHANES periodontal examination protocols. J Dent Res 2010;89:1208-1213.
Albandar JM: Periodontal disease surveillance. J Periodontol 2007;78:1179-1181.
Eke P: Developing new case definitions for monitoring the nation's periodontal health. Dent Abstr 2009;54:63-64.
Page RC, Eke PI: Case definitions for use in population-based surveillance of periodontitis. J Periodontol 2007;78:1387-1399.
NHANES III Household Adult Data File Documentation: Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994, 1998.
Gunter EW, Lewis BG, Koncikowski SM: Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994, 1996.
Dye BA, Tan S, Smith V, Lewis BG, Barker LK, Thornton-Evans G, Eke PI, Beltran-Aguilar ED, Horowitz AM, Li CH: Trends in oral health status: United States, 1988-1994 and 1999-2004. Vital Health Stat 2007;11:1-92.
Eke PI, Genco RJ: CDC periodontal disease surveillance project: background, objectives, and progress report. J Periodontol 2007;78:1366-1371.
US Renal Data System: USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2013.
Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E; PEACE Investigators: Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 2007;115:1528-1536.
Ioannidou E, Swede H, Dongari-Bagtzoglou A: Periodontitis predicts elevated C-reactive protein levels in chronic kidney disease. J Dent Res 2011;90:1411-1415.
Scannapieco FA, Panesar M: Periodontitis and chronic kidney disease. J Periodontol 2008;79:1617-1619.
Miyamoto T, Carrero JJ, Stenvinkel P: Inflammation as a risk factor and target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens 2011;20:662-668.
Kshirsagar AV, Craig RG, Beck JD, Moss K, Offenbacher S, Kotanko P, Yoshino M, Levin NW, Yip JK, Almas K, Lupovici E, Falk RJ: Severe periodontitis is associated with low serum albumin among patients on maintenance hemodialysis therapy. Clin J Am Soc Nephrol 2007;2:239-244.
Ioannidou E, Shaqman M, Burleson J, Dongari-Bagtzoglou A: Periodontitis case definition affects the association with renal function in kidney transplant recipients. Oral Dis 2010;16:636-642.
Li X, Tse HF, Yiu KH, Li LS, Jin L: Effect of periodontal treatment on circulating CD34+ cells and peripheral vascular endothelial function: a randomized controlled trial. J Clin Periodontol 2011;38:148-156.
Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, Suvan J, Hingorani AD, Vallance P, Deanfield J: Treatment of periodontitis and endothelial function. N Engl J Med 2007;356:911-920.
Artese HP, Sousa CO, Luiz RR, Sansone C, Torres MC: Effect of non-surgical periodontal treatment on chronic kidney disease patients. Braz Oral Res 2010;24:449-454.
Vilela EM, Bastos JA, Fernandes N, Ferreira AP, Chaoubah A, Bastos MG: Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease. Clinics (Sao Paulo) 2011;66:657-662.
Graziani F, Cei S, La Ferla F, Vano M, Gabriele M, Tonetti M: Effects of non-surgical periodontal therapy on the glomerular filtration rate of the kidney: an exploratory trial. J Clin Periodontol 2010;37:638-643.
Albandar J: Underestimation of periodontitis in NHANES surveys. J Periodontol 2011;82:337-341.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.